HSPB7 — Heat Shock Protein Family B7

HSPB7 — Heat Shock Protein Family B7

<div class="infobox infobox-gene">
| | |
|---|---| [@hsp2003]
| Gene Name | HSPB7 | [@gene2010]
| Full Name | Heat Shock Protein Family B Member 7 | [@hspb2008]
| Previous Symbols | HSP20 | [@hspb2010]
| Chromosomal Location | 2p23.3 | [@hspb2012]
| UniProt ID | [Q9UBW9](https://www.uniprot.org/uniprot/Q9UBW9) | [@hspb2010a]
| Protein Family | Small Heat Shock Protein (sHSP) Family |
| Molecular Weight | ~17 kDa |
</div>

Overview

HSPB7 (Heat Shock Protein Family B Member 7), also historically known as HSP20, is a member of the small heat shock protein (sHSP) family. Unlike larger [heat shock proteins](/entities/heat-shock-proteins), sHSPs function primarily as ATP-independent molecular chaperones that prevent protein aggregation and maintain cellular proteostasis [1](https://pubmed.ncbi.nlm.nih.gov/10444364/). HSPB7 is expressed predominantly in muscle tissue and the nervous system, where it exhibits anti-apoptotic and neuroprotective properties relevant to neurodegenerative diseases.

Molecular Function

HSPB7 belongs to the small heat shock protein family, characterized by a conserved alpha-crystallin domain of approximately 90 amino acids flanked by N-terminal and C-terminal regions of variable length. The protein forms oligomeric structures (typically 12-24 subunits) that can dynamically assemble and disassemble in response to cellular stress [2](https://pubmed.ncbi.nlm.nih.gov/10662564/).

Key molecular functions include:

HSPB7 — Heat Shock Protein Family B7

<div class="infobox infobox-gene">
| | |
|---|---| [@hsp2003]
| Gene Name | HSPB7 | [@gene2010]
| Full Name | Heat Shock Protein Family B Member 7 | [@hspb2008]
| Previous Symbols | HSP20 | [@hspb2010]
| Chromosomal Location | 2p23.3 | [@hspb2012]
| UniProt ID | [Q9UBW9](https://www.uniprot.org/uniprot/Q9UBW9) | [@hspb2010a]
| Protein Family | Small Heat Shock Protein (sHSP) Family |
| Molecular Weight | ~17 kDa |
</div>

Overview

HSPB7 (Heat Shock Protein Family B Member 7), also historically known as HSP20, is a member of the small heat shock protein (sHSP) family. Unlike larger [heat shock proteins](/entities/heat-shock-proteins), sHSPs function primarily as ATP-independent molecular chaperones that prevent protein aggregation and maintain cellular proteostasis [1](https://pubmed.ncbi.nlm.nih.gov/10444364/). HSPB7 is expressed predominantly in muscle tissue and the nervous system, where it exhibits anti-apoptotic and neuroprotective properties relevant to neurodegenerative diseases.

Molecular Function

HSPB7 belongs to the small heat shock protein family, characterized by a conserved alpha-crystallin domain of approximately 90 amino acids flanked by N-terminal and C-terminal regions of variable length. The protein forms oligomeric structures (typically 12-24 subunits) that can dynamically assemble and disassemble in response to cellular stress [2](https://pubmed.ncbi.nlm.nih.gov/10662564/).

Key molecular functions include:

Chaperone Activity: HSPB7 binds to partially unfolded proteins, preventing their aggregation into toxic oligomers. This function is particularly important under conditions of cellular stress, including oxidative stress, heat shock, and proteasome inhibition.

Anti-Apoptotic Function: HSPB7 inhibits the apoptotic pathway at multiple points. The protein can interact with caspase-3 and caspase-9, preventing their activation and subsequent execution of [apoptosis](/entities/apoptosis) [3](https://pubmed.ncbi.nlm.nih.gov/12471042/). This anti-apoptotic function is crucial for neuronal survival.

Cytoskeletal Stabilization: HSPB7 interacts with cytoskeletal proteins, including actin and desmin, helping to maintain cellular architecture under stress conditions. This function is particularly important in muscle cells and [neurons](/entities/neurons) with extensive cytoskeletal networks.

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis (ALS)

HSPB7 has been extensively studied in the context of ALS, a progressive neurodegenerative disease characterized by loss of motor neurons. Several lines of evidence support a protective role for HSPB7 in ALS:

Dysregulation in ALS: Gene expression studies have shown altered HSPB7 levels in ALS patient spinal cord and motor [cortex](/brain-regions/cortex) [4](https://pubmed.ncbi.nlm.nih.gov/20385768/). While some studies report increased HSPB7 expression as a compensatory response, others suggest functional impairment of the protein.

Protective Effects: Overexpression of HSPB7 in cellular and animal models of ALS protects motor neurons from various insults, including oxidative stress and excitotoxicity [5](https://pubmed.ncbi.nlm.nih.gov/18599467/). The anti-apoptotic function of HSPB7 is particularly relevant, as motor neuron death in ALS occurs predominantly through apoptotic mechanisms.

Genetic Associations: Single nucleotide polymorphisms (SNPs) in the HSPB7 gene have been investigated as potential genetic modifiers of ALS, though results have been inconsistent across different populations.

Parkinson's Disease

In Parkinson's disease (PD), HSPB7 may play protective roles against dopaminergic neuron loss:

Expression Studies: HSPB7 expression is altered in PD brain tissue, particularly in the substantia nigra where dopaminergic neurons degenerate [6](https://pubmed.ncbi.nlm.nih.gov/19813250/). The changes may reflect both protective upregulation and age-related decline in chaperone function.

Alpha-Synuclein Aggregation: HSPB7 can inhibit alpha-synuclein aggregation, a key pathological feature of PD [7](https://pubmed.ncbi.nlm.nih.gov/22426538/). By preventing the formation of toxic alpha-synuclein oligomers, HSPB7 may slow PD progression.

Mitochondrial Protection: HSPB7 helps maintain mitochondrial function under stress conditions, which is particularly relevant to PD given the central role of mitochondrial dysfunction in dopaminergic neuron vulnerability.

Alzheimer's Disease

In Alzheimer's disease (AD), HSPB7 may help protect neurons from [amyloid-beta](/proteins/amyloid-beta) toxicity:

Amyloid-Beta Protection: HSPB7 can reduce amyloid-beta-induced cell death in neuronal cultures [8](https://pubmed.ncbi.nlm.nih.gov/20139080/). The chaperone activity of HSPB7 may help mitigate the cellular stress caused by amyloid-beta accumulation.

Tau Pathology: Some studies suggest HSPB7 may interact with [tau protein](/proteins/tau), though the functional significance remains unclear. The relationship between sHSPs and tau pathology is an active area of research.

Cardiomyopathy and Muscular Dystrophy

While not directly related to neurodegeneration, HSPB7 mutations cause dilated cardiomyopathy (DCM), highlighting its essential role in maintaining cellular proteostasis in high-energy-demand tissues. The lessons learned from cardiac muscle disease may inform therapeutic strategies for neurodegenerative conditions.

Expression Patterns

HSPB7 shows tissue-specific expression, with highest levels in cardiac muscle, skeletal muscle, and the pancreas. In the nervous system, HSPB7 is expressed in various brain regions, including the cerebral cortex, [hippocampus](/brain-regions/hippocampus), and spinal cord. Expression is upregulated in response to cellular stress, including heat shock, oxidative stress, and proteasome inhibition.

Therapeutic Implications

HSPB7 represents a promising therapeutic target for neurodegenerative diseases. Strategies under investigation include:

Small Molecule Modulators: Compounds that enhance HSPB7 expression or activity could provide neuroprotective effects.

Gene Therapy: Viral delivery of HSPB7 to the brain or spinal cord is being explored in preclinical models.

Combination Therapy: Given the complex pathogenesis of neurodegenerative diseases, HSPB7 modulation may be most effective in combination with other therapeutic approaches targeting protein aggregation, neuroinflammation, or mitochondrial dysfunction.

See Also

• [Heat Shock Proteins](/heat-shock-proteins)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Molecular Chaperones](/mechanisms/molecular-chaperones)

References